Harris Todd

President and CEO at TYRA; Head of Corporate Development at Sienna Biopharmaceuticals, Inc.

Sold, on record
$9.3M
Dollars the filings state
Form 4 sales
21
Latest Oct 21, 2024
Form 144 notices
5
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice TYRANotice
    Sep 18, 2024 2024

    Filed to sell 15,000 shares ($360k)

    Harris Todd, Officer

    10b5-1 plan0.8x usual sizeFiling

  2. 2 Form 144 notice TYRANotice
    Sep 20, 2024 +2 days

    Filed to sell 60,000 shares ($1.4M)

    Harris Todd, Officer

    10b5-1 plan3x usual sizeFiling

  3. 3 Form 4 sale TYRARoutine
    Sep 20, 2024 same day

    Sold 16,307 shares at $24.19 ($394k)

    Harris Todd, President and CEO

    10b5-1 planSold 1.1% of holdings ($36.4M position)1.5M shares left0.8x usual sizeFollows a Form 144Filing

  4. 4 Form 4 sale TYRARoutine
    Sep 25, 2024 +5 days

    Sold 11,747 shares at $24.11 ($283k)

    Harris Todd, President and CEO

    10b5-1 planSold 0.8% of holdings ($35.9M position)1.5M shares left0.6x usual sizeFollows a Form 144Filing

  5. 5 Form 4 sale TYRARoutine
    Sep 30, 2024 +5 days

    Sold 500 shares at $24.00 ($12k)

    Harris Todd, President and CEO

    10b5-1 planSold 0% of holdings ($35.5M position)1.5M shares left0x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice TYRANotice
    Oct 16, 2024 +16 days

    Filed to sell 75,000 shares ($1.8M)

    Harris Todd, Officer

    10b5-1 plan4.6x usual sizeFiling

  7. 7 Form 4 sale TYRAUnusual
    Oct 17, 2024 +1 day

    Sold 58,726 shares at $25.77 ($1.5M)

    Harris Todd, President and CEO

    10b5-1 planSold 4% of holdings ($38.1M position)1.4M shares left3.6x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale TYRAUnusual
    Oct 21, 2024 +4 days

    Sold 62,720 shares at $27.28 ($1.7M)

    Harris Todd, President and CEO

    10b5-1 planSold 4.4% of holdings ($38.7M position)1.4M shares left3.5x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (26)

Form 144 notices and Form 4 sales by Harris Todd
Source
Oct 21, 2024Oct 22, 2024TYRAPresident and CEOForm 4 sale62,720$1.7M4.4%UnusualSEC
Oct 17, 2024Oct 17, 2024TYRAPresident and CEOForm 4 sale58,726$1.5M4.0%UnusualSEC
Oct 16, 2024Oct 16, 2024TYRAOfficerForm 144 notice75,000$1.8MNoticeSEC
Sep 30, 2024Oct 2, 2024TYRAPresident and CEOForm 4 sale500$12k0.0%RoutineSEC
Sep 25, 2024Sep 25, 2024TYRAPresident and CEOForm 4 sale11,747$283k0.8%RoutineSEC
Sep 20, 2024Sep 20, 2024TYRAPresident and CEOForm 4 sale16,307$394k1.1%RoutineSEC
Sep 20, 2024Sep 20, 2024TYRAOfficerForm 144 notice60,000$1.4MNoticeSEC
Sep 18, 2024Sep 18, 2024TYRAOfficerForm 144 notice15,000$360kNoticeSEC
Feb 5, 2024Feb 6, 2024TYRAPresident and CEOForm 4 sale100,000$1.7M6.2%UnusualSEC
Feb 2, 2024Feb 2, 2024TYRAOfficerForm 144 notice100,000$1.6MNoticeSEC
Jun 23, 2023Jun 26, 2023TYRAChief Executive OfficerForm 4 sale24,190$412k1.5%RoutineSEC
Jun 21, 2023Jun 21, 2023TYRAChief Executive OfficerForm 4 sale75,810$1.3M4.5%UnusualSEC
Jun 16, 2023Jun 16, 2023TYRAOfficerForm 144 notice100,000$1.6MNoticeSEC
Jun 15, 2023Jun 15, 2023TYRAChief Executive OfficerForm 4 sale20,700$333k1.2%UnusualSEC
Apr 3, 2023Apr 5, 2023TYRAChief Executive OfficerForm 4 sale2,000$32k0.1%RoutineSEC
Mar 31, 2023Mar 31, 2023TYRAChief Executive OfficerForm 4 sale4,327$70k0.3%No planSEC
Mar 28, 2023Mar 28, 2023TYRAChief Executive OfficerForm 4 sale5,912$95k0.3%No planSEC
Mar 23, 2023Mar 23, 2023TYRAChief Executive OfficerForm 4 sale19,236$308k1.1%No planSEC
Apr 30, 2018May 2, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale100$2k0.0%Plan not statedSEC
Apr 25, 2018Apr 25, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale975$20k0.2%Plan not statedSEC
Apr 18, 2018Apr 19, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale18,011$362k3.1%UnusualSEC
Apr 10, 2018Apr 12, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale3,779$76k0.6%Plan not statedSEC
Apr 9, 2018Apr 9, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale8,210$164k1.4%Plan not statedSEC
Mar 19, 2018Mar 20, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale5,876$118k1.0%Plan not statedSEC
Mar 12, 2018Mar 14, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale3,452$69k0.6%Plan not statedSEC
Mar 9, 2018Mar 9, 2018Sienna Biopharmaceuticals, Inc.Head of Corporate DevelopmentForm 4 sale20,672$414k3.3%Plan not statedSEC